Introduction.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Despite recent advances in the understanding and management of depression and anxiety, these disorders remain a challenge for the practicing clinician. As many as one third of patients with depression do not respond to monotherapy with an antidepressant.¹Thehuman and economic impact of depression remains high; unipolar depression is expected tobecome the most common cause of disability in developed countries within the next severalyears.²‘ ‹